A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.
An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...